Sandrine Cure
London, ENG EC2M1QS, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
CEFEPIME/ENMETAZOBACTAM: Physicochemical Stability of a Novel β-Lactam/β-Lactamase Inhibitor Combination in Syringes and Elastomeric Devices.
Journal: Antibiotics (Basel, Switzerland)
Published: December 26, 2025
Efficacy of treatment options for complicated urinary tract infections including acute pyelonephritis: a systematic literature review and network meta-analysis.
Journal: Journal of comparative effectiveness research
Published: January 16, 2025
The Cost of Adrenal Insufficiency in England-Analysis of NHS HES Data.
Journal: Clinical endocrinology
Published: July 09, 2024
Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events.
Journal: Journal of hepatology
Published: March 14, 2021
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysis.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: November 26, 2020
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018.
Journal: The European journal of health economics : HEPAC : health economics in prevention and care
Published: February 20, 2020
Cost-utility evaluation of vortioxetine in patients with Major Depressive Disorder experiencing inadequate response to alternative antidepressants in the United Kingdom.
Journal: Journal of affective disorders
Published: November 28, 2016
Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: September 30, 2016
Cost-utility analysis of ledipasvir/sofosbuvir for the treatment of genotype 1 chronic hepatitis C in Japan.
Journal: Current medical research and opinion
Published: September 10, 2016
Cost-utility analysis of sofosbuvir for the treatment of genotype 2 chronic hepatitis C in Japan.
Journal: Current medical research and opinion
Published: September 09, 2016
Cost-effectiveness of sofosbuvir plus ribavirin with or without pegylated interferon for the treatment of chronic hepatitis C in Italy.
Journal: Journal of medical economics
Published: April 21, 2015
Last Updated: 09/26/2026